These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 29909502

  • 1. Increased NGAL level associated with iron store in chronic kidney disease with anemia.
    Xiang D, Wang X, Liu P, Pan Y, Zhang Q, Chi X, Jing Y, Duan X, Wei Q, Wang J, Li M, Wang C.
    Clin Exp Med; 2018 Nov; 18(4):563-568. PubMed ID: 29909502
    [Abstract] [Full Text] [Related]

  • 2. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY, Kim JH, Lee DW, Lee SB, Rhee H, Song SH, Seong EY, Kwak IS.
    Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
    [Abstract] [Full Text] [Related]

  • 3. Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease.
    Eisenga MF, Nolte IM, van der Meer P, Bakker SJL, Gaillard CAJM.
    BMC Nephrol; 2018 Sep 12; 19(1):225. PubMed ID: 30208847
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
    Emans ME, Braam B, Diepenbroek A, van der Putten K, Cramer MJ, Wielders JP, Swinkels DW, Doevendans PA, Gaillard CA.
    Kidney Blood Press Res; 2012 Sep 12; 36(1):344-54. PubMed ID: 23235391
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients.
    Bolignano D, Coppolino G, Romeo A, De Paola L, Buemi A, Lacquaniti A, Nicocia G, Lombardi L, Buemi M.
    Nephrol Dial Transplant; 2009 Nov 12; 24(11):3398-403. PubMed ID: 19549696
    [Abstract] [Full Text] [Related]

  • 6. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A, Bhandari S.
    Trials; 2019 Apr 04; 20(1):194. PubMed ID: 30947751
    [Abstract] [Full Text] [Related]

  • 7. Etiological spectrum of anemia in non-dialysis-dependent chronic kidney disease: A single-center study from India.
    Vikrant S.
    Saudi J Kidney Dis Transpl; 2019 Apr 04; 30(4):932-942. PubMed ID: 31464252
    [Abstract] [Full Text] [Related]

  • 8. Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.
    Guedes M, Muenz DG, Zee J, Bieber B, Stengel B, Massy ZA, Mansencal N, Wong MMY, Charytan DM, Reichel H, Waechter S, Pisoni RL, Robinson BM, Pecoits-Filho R, CKDopps Investigators.
    J Am Soc Nephrol; 2021 Aug 04; 32(8):2020-2030. PubMed ID: 34244326
    [Abstract] [Full Text] [Related]

  • 9. Iron Deficiency Anemia in Chronic Kidney Disease.
    Gafter-Gvili A, Schechter A, Rozen-Zvi B.
    Acta Haematol; 2019 Aug 04; 142(1):44-50. PubMed ID: 30970355
    [Abstract] [Full Text] [Related]

  • 10. Serum total iron-binding capacity and iron status in patients with non-dialysis-dependent chronic kidney disease: A cross-sectional study in Vietnam.
    Thang LV, Kien NT, Hung NV, Kien TQ, Dung NH, Huong NTT, Toan ND, Toan PQ, Vinh HT, Nghia VX, Usui T.
    Asia Pac J Clin Nutr; 2020 Aug 04; 29(1):48-54. PubMed ID: 32229441
    [Abstract] [Full Text] [Related]

  • 11. A 3-marker index improves the identification of iron disorders in CKD anaemia.
    Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Stengel B, NephroTest Study Group.
    PLoS One; 2014 Aug 04; 9(2):e84144. PubMed ID: 24586229
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow macrophage iron content and sideroblast count in iron- and ESA-naïve patients with CKD-related anemia.
    Capusa C, Mehedinti AM, Bârsan L, Stanciu A, Calenic A, Mircescu G.
    Ren Fail; 2023 Dec 04; 45(1):2230300. PubMed ID: 37408484
    [Abstract] [Full Text] [Related]

  • 13. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, Wang C.
    Int J Clin Exp Pathol; 2014 Dec 04; 7(10):7172-81. PubMed ID: 25400814
    [Abstract] [Full Text] [Related]

  • 14. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
    Ueda N, Takasawa K.
    Nutrients; 2018 Aug 27; 10(9):. PubMed ID: 30150549
    [Abstract] [Full Text] [Related]

  • 15. Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa.
    Nalado AM, Mahlangu JN, Duarte R, Paget G, Olorunfemi G, Jacobson BF, Naicker S.
    PLoS One; 2018 Aug 27; 13(10):e0204899. PubMed ID: 30281654
    [Abstract] [Full Text] [Related]

  • 16. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
    Hildegard Stancu S, Stanciu A, Lipan M, Capusa C.
    J Med Life; 2018 Aug 27; 11(4):293-298. PubMed ID: 30894885
    [Abstract] [Full Text] [Related]

  • 17.
    Chung M, Moorthy D, Hadar N, Salvi P, Iovin RC, Lau J.
    ; 2012 10 27. PubMed ID: 23230575
    [Abstract] [Full Text] [Related]

  • 18. Serum ferritin <70 μg/L predicts functional iron deficiency in patients with chronic kidney disease.
    Garg N, Kotru M, Yadav A, Rusia U, Sikka M, Kalra OP.
    Saudi J Kidney Dis Transpl; 2018 10 27; 29(5):1035-1041. PubMed ID: 30381498
    [Abstract] [Full Text] [Related]

  • 19. Association between neutrophil gelatinase-associated lipocalin (NGAL) and iron profile in chronic renal disease.
    Aghsaeifard Z, Alizadeh R, Bagheri N.
    Arch Physiol Biochem; 2022 Jun 27; 128(3):703-707. PubMed ID: 31994917
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of NGAL in early stage chronic kidney disease.
    Basturk T, Sari O, Koc Y, Eren N, Isleem M, Kara E, Sevinc M, Sakaci T, Ahbap E, Hasbal NB, Bayrakdar Caglayan F, Unsal A.
    Minerva Urol Nefrol; 2017 Jun 27; 69(3):307-312. PubMed ID: 27768023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.